Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
No screener snapshot for this ticker.
Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. Our principal executive offices are located in Reno, Nevada.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
No annual data.
| Line item | Q2 '25 | Q2 '26 |
|---|---|---|
| Revenue | — | — |
| Gross profit | — | — |
| Operating income | -$456,981.00 | -$2.4M |
| Net income | -$458,050.00 | -$2.3M |
| Diluted EPS | -$0.05 | -$0.11 |
| Operating cash flow | — | — |
| Free cash flow | — | — |
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-18 | Purcell Lynn Sebastian | Buy | 202,500 | $0.80 | $162,000.00 | filing |
| 2026-06-18 | Wright Michael G. | Option exercise | 250,000 | $0.00 | $250.00 | filing |
| 2026-05-26 | Wright Michael G. | Option exercise | 400,000 | $0.00 | $400.00 | filing |
| 2026-05-22 | Sharpe Jeffrey Nathan | Option exercise | 500,000 | $0.00 | $500.00 | filing |
| 2026-05-14 | Lorenc Zbigniew Paul | Award | 11,175 | $0.00 | $0.00 | filing |
| 2026-05-12 | OnePointTwo Capital Ventures LLC | Buy | 422,500 | $0.80 | $338,000.00 | filing |
| 2026-05-12 | Purcell Lynn Sebastian | Buy | 422,500 | $0.80 | $338,000.00 | filing |
Latest 7 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.